​

Exact Sciences (EXAS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

EXAS Stock Forecast

Exact Sciences (EXAS) stock forecast, based on 40 Wall Street analysts, predicts a 12-month average price target of $63.40, with a high of $70.00 and a low of $46.00. This represents a 0.16% increase from the last price of $63.30.

$40 $47 $54 $61 $68 $75 High: $70 Avg: $63.4 Low: $46 Last Closed Price: $63.3

EXAS Stock Rating

Exact Sciences stock's rating consensus is Buy, based on 40 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 30 Buy (75.00%), 8 Hold (20.00%), 2 Sell (5.00%), and 0 Strong Sell (0.00%).

Buy
Total 40 0 2 8 30 Strong Sell Sell Hold Buy Strong Buy

EXAS Price Target Upside V Benchmarks

TypeNameUpside
StockExact Sciences0.16%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks8.42%

Price Target Trends

1M3M12M
# Anlaysts459
Avg Price Target$67.75$63.40$64.33
Last Closing Price$63.30$63.30$63.30
Upside/Downside7.03%0.16%1.63%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 253182--23
Sep, 253183--24
Aug, 254183--25
Jul, 255183--26
Jun, 255184--27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 08, 2025Piper Sandler$70.00$57.7521.21%10.58%
Oct 07, 2025Vijay KumarEvercore ISI$68.00$57.6317.99%7.42%
Oct 02, 2025Luke SergottBarclays$65.00$56.4315.19%2.69%
Oct 01, 2025Wells Fargo$68.00$54.7124.29%7.42%
Aug 07, 2025Conor McNamaraRBC Capital$46.00$41.3411.27%-27.33%
Mar 28, 2025Subbu NambiGuggenheim$60.00$44.9933.36%-5.21%
Jan 02, 2025Vijay KumarEvercore ISI$70.00$56.9322.96%10.58%
Nov 06, 2024Catherine SchulteRobert W. Baird$67.00$72.42-7.48%5.85%
Nov 06, 2024Mark MassaroBTIG$65.00$72.42-10.25%2.69%
Oct 29, 2024Kyle MiksonCanaccord Genuity$95.00$69.3536.99%50.08%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 08, 2025Piper SandlerOverweightOverweighthold
Oct 07, 2025Evercore ISIOutperformOutperformhold
Oct 02, 2025BarclaysOverweightOverweighthold
Aug 07, 2025Cowen & Co.BuyBuyhold
Jul 09, 2025Raymond JamesOutperformPerformupgrade
Mar 28, 2025GuggenheimBuyBuyhold
Jan 02, 2025Evercore ISIOutperformOutperformhold
Oct 29, 2024Wells FargoBuyBuyhold
Oct 29, 2024Canaccord GenuityBuyBuyhold
Oct 04, 2024Leerink PartnersOutperformOutperformhold

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-5.61$-3.48$-3.54$-1.13$-5.59----
Avg Forecast$-2.98$-3.11$-3.63$-1.28$-1.16$-0.31$0.58$1.02$1.29
High Forecast$-2.94$-3.07$-3.55$-1.25$-1.10$0.10$1.48$2.01$1.33
Low Forecast$-3.05$-3.19$-3.70$-1.37$-1.23$-1.18$-0.70$-0.11$1.26
Surprise %88.26%11.90%-2.48%-11.72%381.90%----

Revenue Forecast

$1B $2B $2B $3B $4B $5B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.49B$1.77B$2.08B$2.50B$2.76B----
Avg Forecast$1.47B$1.74B$2.05B$2.49B$2.75B$3.06B$3.44B$3.79B$4.07B
High Forecast$1.50B$1.78B$2.09B$2.51B$2.76B$3.12B$3.44B$3.81B$4.17B
Low Forecast$1.45B$1.72B$2.02B$2.45B$2.74B$3.03B$3.44B$3.77B$4.00B
Surprise %1.59%1.38%1.48%0.37%0.44%----

Net Income Forecast

$-6B $-4B $-3B $-2B $-700M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-848.53M$-595.63M$-623.51M$-204.15M$-1.03B----
Avg Forecast$-4.55B$-483.64M$-726.05M$-204.15M$-214.04M$-92.28M$66.66M$183.02M$232.39M
High Forecast$-3.64B$-386.91M$-580.84M$-163.32M$-198.19M$18.02M$266.73M$361.87M$239.16M
Low Forecast$-5.46B$-580.37M$-871.25M$-244.98M$-220.79M$-212.48M$-125.70M$-19.61M$226.88M
Surprise %-81.37%23.15%-14.12%-380.69%----

EXAS Forecast FAQ

Is Exact Sciences stock a buy?

Exact Sciences stock has a consensus rating of Buy, based on 40 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 30 Buy, 8 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Exact Sciences is a favorable investment for most analysts.

What is Exact Sciences's price target?

Exact Sciences's price target, set by 40 Wall Street analysts, averages $63.4 over the next 12 months. The price target range spans from $46 at the low end to $70 at the high end, suggesting a potential 0.16% change from the previous closing price of $63.3.

How does Exact Sciences stock forecast compare to its benchmarks?

Exact Sciences's stock forecast shows a 0.16% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (8.42%).

What is the breakdown of analyst ratings for Exact Sciences over the past three months?

  • October 2025: 13.04% Strong Buy, 78.26% Buy, 8.70% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 12.50% Strong Buy, 75.00% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 16.00% Strong Buy, 72.00% Buy, 12.00% Hold, 0% Sell, 0% Strong Sell.

What is Exact Sciences’s EPS forecast?

Exact Sciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.31, marking a -94.45% decrease from the reported $-5.59 in 2024. Estimates for the following years are $0.58 in 2026, $1.02 in 2027, and $1.29 in 2028.

What is Exact Sciences’s revenue forecast?

Exact Sciences's average annual revenue forecast for its fiscal year ending in December 2025 is $3.06B, reflecting a 10.77% increase from the reported $2.76B in 2024. The forecast for 2026 is $3.44B, followed by $3.79B for 2027, and $4.07B for 2028.

What is Exact Sciences’s net income forecast?

Exact Sciences's net income forecast for the fiscal year ending in December 2025 stands at $-92.282M, representing a -91.03% decrease from the reported $-1.029B in 2024. Projections indicate $66.66M in 2026, $183.02M in 2027, and $232.39M in 2028.